To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
16 Current news of Saltigorss
Saltigo GmbH will be raising its prices for the product group 1,2,4-triazole by 1.65/kg effective January 1, 2013. The reasons for the measure are increases in raw material, energy and logistic costs. In light of the increase in operational costs associated with the production and to secure ...
LANXESS’ subsidiary again awarded by Syngenta for outstanding relationship
Syngenta has presented Saltigo GmbH with an award for its commitment and contribution to the partnership between both companies. Saltigo received the Global Sourcing Award of Recognition 2012 for Partnership at the Syngenta Supplier Conference, held during the ChemSpec Europe chemistry trade ...
Joerg Schneider succeeds Uwe Brunk
Effective February 1, 2012, Joerg Schneider, Managing Director of LANXESS Elastômeros do Brasil S.A., will assume management of the Agro & Fine Chemicals business line of Saltigo GmbH. The 49-year-old will succeed Dr. Uwe Brunk, who is leaving the company at his own request. Schneider began ...
Nobel Prize-winning chemistry in industrial use
Palladium-catalyzed cross-coupling reactions have become an important cornerstone of modern organic synthesis chemistry. They have made a wide variety of active pharmaceutical ingredients, natural substances and other complex organic molecules economically accessible. The award of this year's ...
Saltigo GmbH, the specialist in custom synthesis based in Langenfeld, Germany, and Reuter Chemische Apparatebau KG (RCA) of Freiburg, Germany, concluded a cooperation agreement on October 1. The companies will jointly develop processes for the synthesis of active pharmaceutical ingredients ...
Saltigo GmbH has passed an audit by the U.S. Food and Drug Administration (FDA) with a “No Findings” rating. Saltigo’s Managing Director Wolfgang Schmitz is delighted that the official auditors did not have any objections: “The FDA audit is an internationally accredited seal of quality and ...
Syngenta invests around EUR 50 million in Saltigo facilities
Saltigo, a wholly owned subsidiary of LANXESS, is significantly expanding production at its Leverkusen site. This is being made possible by a cooperation agreement that is so far unique for the Group. Syngenta is investing some EUR 50 million in expanding several Saltigo facilities in ...
LANXESS subsidiary wins “Agrow Award 2009”
Saltigo GmbH, a wholly owned subsidiary of LANXESS, has been rated as “Best Supplier” by the “Agrow” trade journal for the second time in succession and won against a strong competition from India, China and Europe. A panel of judges comprising eleven internationally recognized experts from ...
Saltigo GmbH targets Japanese custom manufacturing market, presenting its portfolio of services at Interphex/Pharma-i Japan Exhibition in Tokyo. Saltigo’s CEO Wolfgang Schmitz emphasizes: “This is Asia’s largest pharmaceutical industry event and has an excellent reputation for attracting key ...